Inovio Pharmaceuticals, Inc. Financial Ratios — INO Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-26.03	-37.03	-98.97	-32.83	-16.89	-38.05	-48.87	-60.92	-86.79	-48.68	-58.64	-66.27	-52.02	-75.49	-90.61
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	100	100	100	100	100	100	100	100	100	100	100	100	100	100	100
EBITDA Margin (%)	-206.36	-549.93	-144.39	-362.7	-82.24	-209.65	-192.26	-292.29	-2,567.95	-1,611.8	-16,705.78	-2,553.8	-15,615.57	-50,179.5	-128,297.25
Operating Margin (%)	-226.9	-598.36	-159.97	-377.71	-86.97	-218.38	-200.48	-308.68	-2,702.1	-1,674.25	-16,972.34	-2,607.35	-16,036.67	-51,616.91	-132,871.32
Incremental Operating Margin (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	-156.24	-478.63	-490.69	-345.61	-76.9	-208.49	-208.92	-311	-2,938.01	-2,197.89	-17,085.39	-2,705.57	-16,239.87	-49,254.27	-130,000
Profit Margin (%)	-155.72	-477.56	-490.29	-345.44	-71.94	-208.49	-208.92	-318.12	-2,902.75	-2,245.39	-17,109.87	-2,726.67	-16,239.87	-49,254.27	-130,000
Net Income to Common Margin (%)	-155.72	-477.56	-490.29	-345.44	-71.94	-208.49	-208.92	-318.12	-2,902.75	-2,245.39	-17,109.87	-2,726.67	-16,239.87	-49,254.27	-130,000
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	100	39	33	32	30	12	9
ST Debt	- -	- -	- -	- -	- -	- -	- -	- -	2	2	3	3	19	2	3
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	97	37	30	29	11	9	7
Total Debt/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	-0.94	-0.33	-0.11	-0.12	-0.23	-0.11	-0.11
Net Debt/EBITDA	0.86	0.25	1.73	1.07	1.73	0.26	0.29	0.27	-0.52	1.94	0.19	0.11	-0.02	0.6	0.53
Total Debt/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	-0.9	-0.31	-0.11	-0.12	-0.23	-0.11	-0.11
Net Debt/EBIT	0.78	0.23	1.57	1.03	1.63	0.25	0.28	0.25	-0.49	1.87	0.19	0.11	-0.02	0.59	0.51
EBITDA to Interest Expense	-589.58	- -	- -	- -	- -	- -	-3,130.14	- -	-13.28	-13.73	-153.11	-209	-106.25	-614.45	- -
EBITDA-CapEx/Interest Expense	-594.28	- -	- -	- -	- -	- -	-3,527.08	- -	-13.41	-13.9	-153.74	-209.77	-106.51	-617.19	- -
EBIT to Interest Expense	-648.26	- -	- -	- -	- -	- -	-3,263.91	- -	-13.98	-14.26	-155.55	-213.38	-109.12	-632.05	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	8	9	2	1	1	- -	- -
Common Equity/Total Assets	-343.59	-508.69	-334.97	-251.81	-168.83	-250.29	-279.46	-473.12	-513.84	-167.85	-243.91	-426.88	-949.36	-1,528.47	-2,442.6
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,802.69	7.96	7.61	13.16	9.4	13.67	27.16
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-15.27	-4.24	-2.59	-2.01	-0.69	-0.55	-0.36
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	67.68	6.8	6.13	8.4	6.45	8.28	8.81
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,841.08	8.47	8.26	14.42	25.74	17.32	38.88
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-15.59	-4.5	-2.81	-2.2	-1.9	-0.69	-0.52
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	69.13	7.23	6.66	9.2	17.67	10.48	12.61
Net Debt to Equity	-36.25	-16.2	-63.74	-36.35	-32.76	-15.51	-16.69	-27.22	1,014.4	-50.33	-14.06	-13.36	2.1	-96.07	-183.74
Net Debt/Capital (%)	7.65	2.41	10.25	10.9	13.77	4.22	4.35	3.68	-8.3	20.76	4.5	1.98	-0.15	3.69	2.39
EBITDA	-20	-23	-19	-38	-33	-74	-81	-89	-106	-119	-296	-262	-130	-109	-84
EBITDA-CapEx	-20	-23	-20	-39	-36	-78	-91	-91	-107	-121	-298	-263	-130	-110	-84
Operating Income (Loss)	-22	-25	-22	-39	-35	-77	-85	-94	-111	-124	-301	-268	-133	-112	-87

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	2.74	1.63	1.82	6.65	5.18	2.39	3.6	2.3	2.8	9.87	6.1	2.61	3.41	2.66	1.34
Current Ratio	2.89	1.91	2.03	7.02	5.46	2.84	3.91	2.49	2.94	11.3	6.82	3.25	3.6	2.77	1.4
Quick Ratio	2.78	1.74	1.93	6.85	5.41	2.77	3.78	2.42	2.86	10.33	6.23	2.73	3.47	2.7	1.34
CFO/Avg Current Liab	-2.26	-2.3	-0.82	-1.39	-0.55	-1.66	-1.6	-2.08	-2.91	-4.83	-4.02	-2.66	-1.78	-2.67	-2.24
Common Equity/Total Assets	-343.59	-508.69	-334.97	-251.81	-168.83	-250.29	-279.46	-473.12	-513.84	-167.85	-243.91	-426.88	-949.36	-1,528.47	-2,442.6
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,802.69	7.96	7.61	13.16	9.4	13.67	27.16
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-15.27	-4.24	-2.59	-2.01	-0.69	-0.55	-0.36
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	67.68	6.8	6.13	8.4	6.45	8.28	8.81
Total Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	1,841.08	8.47	8.26	14.42	25.74	17.32	38.88
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-15.59	-4.5	-2.81	-2.2	-1.9	-0.69	-0.52
Total Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	69.13	7.23	6.66	9.2	17.67	10.48	12.61
CFO/Total Liabilities	-149.16	-216.96	-43.47	-147.3	-32.81	-124.29	-141.25	-166.85	-70.63	-226.35	-224.06	-171.37	-232.02	-232.87	-176.5
CFO/CapEx	-122.56	-92.56	-86.94	-21.61	-4.47	-15.88	-6.14	-35.28	-99.05	-117.04	-175.23	-223.1	-387.55	-213.35	-310.22
Altman's Z-Score	-5.52	-10.17	3.05	11.96	5.19	1.36	-0.43	-4.33	-8.79	8.28	1.88	-6.25	-13.57	-23.34	-36.8

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	32.04	6	6.46	3.43	8	2.96	3.66	5.78	1.35	0.7	0.13	1.04	0.12	0.12	0.11
Days Sales Outstanding	11.39	60.84	56.48	106.56	45.6	123.34	99.68	63.13	270.16	519.48	2,786.29	351.59	3,102.34	3,020.73	3,350.17
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	54	68	535	543	458	508	338	370	326	1,373	1,042	372	136	50	82
- Cash & Cash Equivalents	17	6	34	41	58	19	24	24	22	251	71	46	14	66	44
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	1	1	- -	- -	- -	- -	- -	- -	2	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	- -	- -	- -	100	39	33	32	30	12	9
Enterprise Value	25	55	482	449	296	403	210	289	338	1,000	674	151	21	-33	32
Total Capital	-209	-229	-295	-332	-361	-435	-523	-620	-638	-867	-1,177	-1,456	-1,593	-1,718	-1,806
Total Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	-15.59	-4.5	-2.81	-2.2	-1.9	-0.69	-0.52
Total Debt / EV	- -	- -	- -	- -	- -	- -	- -	- -	0.29	0.04	0.05	0.21	1.47	-0.36	0.29
EV/Sales	2.51	13.37	35.82	42.98	7.28	11.41	4.98	9.48	82.13	134.97	379.64	14.75	24.78	- -	496.42
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	54	68	535	545	459	508	338	370	326	1,373	1,042	372	136	50	82
Diluted Enterprise Value	37	63	501	505	402	489	315	347	405	1,161	1,004	358	152	-4	47
EV per Share	9.36	19.37	125.61	91.22	52	66.12	30.88	37.48	41.05	77.38	38.72	7.61	0.93	- -	0.69
TTM Sales	10	4	13	10	41	35	42	30	4	7	2	10	1	- -	- -
TTM EBITDA	-20	-23	-19	-38	-33	-74	-81	-89	-106	-119	-296	-262	-130	-109	-84
TTM Operating Income	-22	-25	-22	-39	-35	-77	-85	-94	-111	-124	-301	-268	-133	-112	-87
TTM Cash Flow to Firm	-20	-22	-15	-30	-12	-63	-63	-74	-90	-169	-214	-215	-123	-104	-89
TTM Free Cash Flow to Firm	-20	-22	-15	-28	-10	-59	-53	-71	-89	-168	-213	-214	-123	-103	-88

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	-2.77	-3.09	-35.16	-19.17	-47.57	-8.67	-6.39	-5.18	-3.36	-7.78	-4.86	-1.73	-1.09	-0.48	-0.92
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	25	55	482	449	296	403	210	289	338	1,000	674	151	21	-33	32
Low Price	16.8	18.24	23.52	89.76	63.84	54	49.08	43.68	23.04	35.4	59.88	16.56	3.84	1.74	1.3
EV/Sales	2.51	13.37	35.82	42.98	7.28	11.41	4.98	9.48	82.13	134.97	379.64	14.75	24.78	- -	496.42
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-6.8	-3.82	-3.59	-17.31	-18.01	-8.29	-5.82	-4.49	-2.58	-10.99	-5.83	-2.15	-1.45	-2.01	-1.11
Price/Earnings High	-12.91	-6.25	-8.46	-25.86	-25.3	-11.61	-9.14	-6.01	-4.23	-31.5	-13.07	-4.49	-3.92	-3.74	-1.64
Price/Earnings Low	-2.9	-2.64	-1.37	-12.24	-12.43	-4.47	-3.79	-3.47	-1.59	-2.75	-3.43	-1.18	-0.63	-0.44	-0.72
Price/Book Value	-0.26	-0.3	-1.81	-1.64	-1.27	-1.17	-0.65	-0.6	-0.44	-1.52	-0.86	-0.25	-0.08	-0.03	-0.04
Price/Book Value Average	-0.49	-0.33	-0.8	-1.88	-1.46	-1.41	-0.98	-0.7	-0.42	-2.02	-1.46	-0.41	-0.12	-0.12	-0.05
Price/Book Value High	-0.94	-0.54	-1.89	-2.82	-2.05	-1.97	-1.54	-0.94	-0.68	-5.79	-3.28	-0.85	-0.33	-0.23	-0.08
Price/Book Value Low	-0.21	-0.23	-0.31	-1.33	-1	-0.76	-0.64	-0.54	-0.26	-0.51	-0.86	-0.22	-0.05	-0.03	-0.03
Price/Tangible Book Value	1.91	3.96	14.42	5.62	2.83	4.83	2.68	5.16	-37.01	3.07	2.7	1.77	1.16	0.73	3.39
Price/Tangible Book Value Average	3.65	4.36	6.4	6.47	3.25	5.81	4.08	6.07	-35.04	4.09	4.58	2.87	1.67	3.15	3.91
Price/Tangible Book Value High	6.93	7.12	15.07	9.67	4.56	8.13	6.4	8.12	-57.31	11.71	10.27	6	4.51	5.85	5.8
Price/Tangible Book Value Low	1.55	3.01	2.44	4.58	2.24	3.13	2.66	4.69	-21.53	1.02	2.7	1.57	0.73	0.69	2.53
Price/Sales	5.54	16.57	39.7	51.91	11.3	14.37	8	12.14	79.23	185.24	587.16	36.27	163.1	228.26	1,248.52
Price/Sales Average	10.58	18.26	17.62	59.81	12.96	17.29	12.17	14.28	75.02	246.85	997.02	58.72	236.19	990.23	1,442.92
Price/Sales High	20.1	29.83	41.48	89.34	18.2	24.2	19.1	19.13	122.68	707.27	2,235.67	122.54	636.42	1,839.78	2,138.28
Price/Sales Low	4.51	12.59	6.71	42.3	8.94	9.32	7.92	11.05	46.09	61.75	587.16	32.09	102.34	217.03	932.81
Price/Cash Flow	-2.75	-3.06	-34.76	-18.2	-36.84	-8.12	-5.34	-5.03	-3.33	-7.71	-4.83	-1.72	-1.09	-0.48	-0.92
Price/Cash Flow Average	-5.25	-3.37	-15.42	-20.97	-42.27	-9.77	-8.13	-5.92	-3.15	-10.28	-8.2	-2.79	-1.58	-2.07	-1.06
Price/Cash Flow High	-9.97	-5.51	-36.32	-31.32	-59.38	-13.68	-12.76	-7.93	-5.16	-29.45	-18.39	-5.82	-4.26	-3.85	-1.58
Price/Cash Flow Low	-2.24	-2.33	-5.87	-14.83	-29.17	-5.27	-5.29	-4.58	-1.94	-2.57	-4.83	-1.52	-0.68	-0.45	-0.69
Price/Free Cash Flow Average	-5.29	-3.41	-15.6	-22.09	-54.57	-10.43	-9.72	-6.09	-3.18	-10.37	-8.25	-2.8	-1.58	-2.08	-1.07
Price/Free Cash Flow High	-10.05	-5.57	-36.74	-33	-76.67	-14.6	-15.26	-8.16	-5.21	-29.71	-18.5	-5.84	-4.27	-3.87	-1.58
Price/Free Cash Flow Low	-2.25	-2.35	-5.94	-15.62	-37.66	-5.62	-6.33	-4.71	-1.96	-2.59	-4.86	-1.53	-0.69	-0.46	-0.69
EV/Sales Average	8.87	17.01	15.15	55.96	11.54	16.75	11.61	13.5	94.3	218.29	975.54	57.33	255.29	742.48	908.73
EV/Sales High	18.39	28.58	39.01	85.49	16.79	23.66	18.54	18.35	141.96	678.71	2,214.19	121.15	655.53	1,592.03	1,604.09
EV/Sales Low	2.8	11.35	4.24	38.45	7.53	8.78	7.36	10.28	65.38	33.19	565.68	30.7	121.45	- -	398.62
EV/EBITDA Average	-4.3	-3.09	-10.49	-15.43	-14.04	-7.99	-6.04	-4.62	-3.67	-13.54	-5.84	-2.25	-1.63	-1.48	-0.71
EV/EBITDA High	-8.91	-5.2	-27.02	-23.57	-20.42	-11.29	-9.64	-6.28	-5.53	-42.11	-13.25	-4.74	-4.2	-3.17	-1.25
EV/EBITDA Low	-1.35	-2.06	-2.93	-10.6	-9.15	-4.19	-3.83	-3.52	-2.55	-2.06	-3.39	-1.2	-0.78	0.06	-0.31
EV/EBIT Average	-3.91	-2.84	-9.47	-14.82	-13.27	-7.67	-5.79	-4.38	-3.49	-13.04	-5.75	-2.2	-1.59	-1.44	-0.68
EV/EBIT High	-8.1	-4.78	-24.38	-22.63	-19.31	-10.83	-9.25	-5.95	-5.25	-40.54	-13.05	-4.65	-4.09	-3.08	-1.21
EV/EBIT Low	-1.23	-1.9	-2.65	-10.18	-8.66	-4.02	-3.67	-3.33	-2.42	-1.98	-3.33	-1.18	-0.76	0.06	-0.3
Last Price	20.64	24	139.2	110.16	80.64	83.28	49.56	48	39.6	106.2	59.88	18.72	6.12	1.83	1.74
High Price	74.88	43.2	145.44	189.6	129.96	140.28	118.32	75.6	61.32	405.48	228	63.24	23.88	14.75	2.98
Enterprise Value Average	87	70	204	585	468	592	490	412	388	1,618	1,731	588	212	162	59
Enterprise Value High	180	118	525	894	681	837	783	559	584	5,030	3,930	1,243	545	347	105
Enterprise Value Low	27	47	57	402	305	310	311	313	269	246	1,004	315	101	-7	26

Shares Outstanding	3	3	4	5	6	6	8	8	8	16	18	21	23	36	69
Diluted Weighted Avg Shares	3	3	4	5	6	6	7	8	8	13	17	20	22	27	47
Basic Weighted Avg Shares	3	3	4	5	6	6	7	8	8	13	17	20	22	27	47
Revenue per Share	3.72	1.45	3.51	2.12	7.14	5.8	6.2	3.95	0.5	0.57	0.1	0.52	0.04	0.01	- -
EBITDA per Share	-7.69	-7.96	-5.06	-7.7	-5.87	-12.15	-11.91	-11.55	-12.84	-9.24	-17.04	-13.18	-5.86	-4.02	-1.79
Operating Income per Share	-8.45	-8.67	-5.61	-8.02	-6.21	-12.66	-12.42	-12.2	-13.51	-9.6	-17.31	-13.46	-6.02	-4.14	-1.85
Basic EPS, GAAP	-5.8	-6.92	-17.19	-7.33	-5.14	-12.09	-12.94	-12.57	-14.51	-12.87	-17.45	-14.07	-6.09	-3.95	-1.81
Basic EPS from Cont Ops	-5.82	-6.93	-17.21	-7.33	-5.12	-12.09	-12.94	-12.57	-14.65	-12.96	-17.45	-14.07	-6.09	-3.95	-1.81
Diluted EPS, GAAP	-5.8	-6.92	-17.19	-7.3	-5.12	-12.09	-12.92	-12.57	-14.51	-12.87	-17.45	-14.07	-6.09	-3.95	-1.81
Diluted EPS from Cont Ops	-5.82	-6.93	-17.21	-7.3	-5.11	-12.09	-12.92	-12.57	-14.65	-12.96	-17.45	-14.07	-6.09	-3.95	-1.81
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-7.51	-7.84	-4	-6.05	-2.19	-10.25	-9.28	-9.54	-11.89	-13.77	-12.4	-10.87	-5.61	-3.83	-1.89
Free Cash Flow per Basic Share	-7.57	-7.93	-4.05	-6.33	-2.68	-10.9	-10.79	-9.81	-12.01	-13.89	-12.47	-10.92	-5.62	-3.85	-1.9
Cash & Equivalents per Share	11.49	4.81	13.7	19	28.68	17.17	18.7	10.53	10.88	31.84	23.06	12.72	6.55	3.47	1.25
Book Value per Share	-79.83	-80.74	-77	-67.35	-63.53	-71.26	-76.78	-80.44	-89.91	-70.09	-69.51	-74.82	-73.19	-63.7	-38.71
Tangible Book Value per Share	10.81	6.07	9.65	19.61	28.49	17.25	18.48	9.31	-1.07	34.62	22.21	10.55	5.29	2.52	0.51

Inovio Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)